Log in to save to my catalogue

Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disea...

Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disea...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_426079

Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease

About this item

Full title

Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews cardiology, 2020-04, Vol.17 (4), p.242-257

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Advances in antiplatelet therapies for patients with cardiovascular disease have improved patient outcomes over time, but the challenge of balancing the risks of ischaemia and bleeding remains substantial. Moreover, many patients with cardiovascular disease have a residual risk of ischaemic events despite receiving antiplatelet therapy. Therefore,...

Alternative Titles

Full title

Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_uu_426079

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_426079

Other Identifiers

ISSN

1759-5002,1759-5010

E-ISSN

1759-5010

DOI

10.1038/s41569-019-0314-y